IFNB1 and encephalomyelitis: When interferon (IFN)-β therapy was combined with NPs, like IFN-carried chitosan/sulfobutylether-cyclodextrin NPs, it was successful in intranasal administration of IFN-β into the central nervous system (CNS), boosting clinical improvement and controlling neurological inflammation in encephalomyelitis (EAE).15 Moreover, nanomaterials can also serve as molecular probes to provide support for imaging diagnosis of inflammatory diseases.